Revolutionizing Precision Medicine

Advancing in vivo cell & gene therapies with targeted delivery technologies.

Product & Services Explore the technology →

Revolutionizing Precision Medicine

Advancing in vivo cell & gene therapies with targeted delivery technologies.

Product & Services Explore the technology →

About Us

Advancing In Vivo Cell & Gene Therapies

With industry leading technical capabilities, we provide a wide range of products and services to support targeted-LNP development in gene editing, in vivo CAR-T, and other groundbreaking therapies. Our services and products include manufacturing of customized tLNPs at various scales, developing tLNP specific assays, and off-the-shelf tLNP products.

Learn more →
A digital illustration of a DNA double helix structure composed of white spheres with some red glowing areas, set against a light gray background.
Close-up of scientist wearing safety glasses examining test tubes with colorful liquids in a laboratory.

Technology

Targeted LNP (tLNP) Formulation and Characterization

Customize and optimize LNP chemistry and composition Scalable process from milligrams to grams.
Customize targeting binders Cell-specific binding moieties, such as Fab or nanobody, precisely conjugated to the LNP, enabling preferential delivery to specific cell types.
See the full technology platform →
3D illustration of a lipid nanoparticle with payload and targeted binder | Targeted Lipid Nanoparticle Delivery Service

Core Capabilities, and the ways we partner.

Core Capabilities

  • LNP and tLNP formulation from screening to scale-up

  • Specialized analytical tests for tLNP characterization

  • Streamlined work flows enabling fast development

  • CMC and GMP readiness

‍ ‍Business Model

  • CRO/CDMO (fee for service)

  • Off-the-shelf products

  • Partnership